Senator Jeff Steinborn joins Sam Chapman to walk through the legislative journey of New Mexico's Senate Bill 219, the first psilocybin access program passed by a state legislature in U.S. history. Steinborn traces the path from a single constituent's phone call to a governor's signature, covering the committees that nearly killed the bill, the unexpected veterans testimony that shifted the room, and why getting the Department of Health involved before drafting began was the move that made everything else possible. The conversation also looks ahead to New Mexico's equity fund, the December program launch, and what other states can learn from how this got done.

Amanda Gow joins Sam Chapman to discuss Bendable Therapy, a psilocybin-assisted therapy model staffed entirely by licensed mental health professionals and built around deep preparation, integration, and ongoing group support. After 15 years in trauma-focused youth services, Amanda founded Bendable to serve the people most often left out of mental health care. The conversation covers what their IRB-approved research is actually showing, why preparation and integration may drive outcomes more than the session itself, and what it would take to bring private insurers and employers into the psilocybin therapy conversation.

Dr. Matthew Hicks, naturopathic doctor, Oregon-licensed psilocybin facilitator, and lead investigator on the first clinical trial conducted inside a state-regulated psychedelic program, joins Sam Chapman to discuss what he found. The conversation covers his group treatment model that cut costs by more than half, the unexpected outcomes his team measured, and why this research could move Medicaid coverage of psilocybin therapy from a hopeful idea to a fundable program.

Retired police lieutenant and Law Enforcement Action Partnership (LEAP) Executive Director Diane Goldstein joins Sam Chapman to discuss drug policy reform, the role of psychedelics in addressing law enforcement trauma, and LEAP's advocacy for psychedelic access and mental health support. The conversation also covers the fiscal case for legal psychedelic access and the broader psychological and societal costs of current drug policy.

To launch Ground Game, Sam Chapman speaks with Dr. Adie Rae, co-director of the Open Psychedelic Evaluation Nexus, the team at the center of a historic $3.3 million NIDA grant to track outcomes in Oregon's legal psilocybin program. The conversation covers what Oregon's program has already revealed about safety and efficacy, what this federal investment signals for the future of psychedelic access nationwide, and much more.